Delivery Order SPE2DB20D2104-SPE2DB25FNBLM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,092.00 to AmerisourceBergen Drug Corp for the supply of Ajovy 225 mg/1.5 mL auto-injector pens. The contract, which was competitively awarded without set-aside designation, was finalized on September 24, 2025, with an ultimate completion date of September 25, 2025. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $6,017.34 to AmerisourceBergen Drug Corp for the supply of AJOVY 225 mg/1.5 mL auto-injector units. This firm fixed-price delivery order, issued on September 29, 2025, represents a non-set-aside, competitively awarded contract with an ultimate completion date of September 30, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $1,199.10 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 225 mg/1.5 mL autoinjector doses of the drug Ajovy. The contract has a completion date of May 12, 2025 and was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $1,820.00 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of AJOVY 225 mg/1.5 ml auto-injector units. The contract, which carries no set-aside designation, represents a competitively awarded order with an ultimate completion date of September 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency (DLA) awarded a $1,943.71 firm fixed price delivery order to AmerisourceBergen Drug Corp for AJOVY (fremanezumab) 225 mg/1.5 mL syringes on September 26, 2025, with completion targeted for September 29, 2025. This non-set-aside award represents a pediatric migraine prevention medication delivery to support federal medical supply requirements. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, to provide 225 mg/1.5 ml Ajovy auto-injectable medication. The $1,421.20 contract has a performance period through March 7, 2024 and does not have a set-aside designation. This delivery order is issued under a larger indefinite delivery contract (IDC) valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,072.34 firm fixed price delivery order is for the supply of Ajovy 225 mg/1.5 ml autoinjector medication. The contract has an ultimate completion date of November 14, 2024 and was awarded on November 13, 2020. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of AJOVY (eptinezumab) 225 mg/1.5 mL auto-injector units valued at $1,187.64. This firm fixed-price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the Place of Performance located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's...
- The Defense Logistics Agency awarded a $6,655.88 delivery order to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 mL auto-injector units, with a completion date of September 30, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is registered in the System for Award Management. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,597.47 to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 ml auto-injector units, with an ultimate completion date of September 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNBLMDelivery Order
The Defense Logistics Agency awarded a $1,293.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Ajovy (fremanezumab) 225 mg/1.5 ml auto-injector units. This is a non-set-aside competitive award with an ultimate completion date of September 25, 2025. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen operates under a significantly larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX) valued at $999,999,999.00 through December 2026, which serves as the overarching vehicle enabling the company to supply pharmaceutical products and medical supplies to military and federal healthcare systems globally. This delivery order represents a routine procurement action under AmerisourceBergen's comprehensive prime IDV with DLA, which covers a broad spectrum of pharmaceutical products across multiple therapeutic domains including specialty medications, brand-name and generic drugs, and medical supplies. The company's federal contract portfolio demonstrates its established capability to fulfill competitive federal medical procurement requirements consistently. The Ajovy auto-injector delivery supports the Defense Health Agency and broader military healthcare programs, reflecting the company's ongoing role as a strategic pharmaceutical supplier for federal defense and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/24/25 |